Saúde
AALR3 — ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A.
CNPJ 42.771.949/0001-35 · listed classes: AALR3 · CVM code 24058
The full history, year by year
The arrow opens the path from the figure down to the line in the regulator's file. A cell with ! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.
| indicator | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE ⟶ | -1.7%! | 1.6% | 0.6% | 3.2% | 3.3% | -7.9% | -0.5% | -21.4% | -24.4% | -12.8% | -335.8% |
| ROIC ⟶ | 5.1%! | 6.2% | 2.8%! | 5.6% | 5.9% | -0.3%! | 3.9% | -1.2%! | 1.4%! | 4.2%! | -74.6%! |
| ROA ⟶ | -0.7%! | 1.6% | 0.7% | 2.3% | 2.2% | -3.7% | 0.1% | -8.5% | -8.3% | -4.0% | -58.8% |
| Gross margin ⟶ | 39.7% | 37.9% | 29.8% | 26.9% | 26.5% | 17.8% | 31.3% | 30.0% | 30.9% | 29.2% | 20.8% |
| EBIT margin ⟶ | 15.5% | 10.6% | 6.5% | 12.7% | 13.3% | -1.0% | 7.8% | -3.0% | 3.3% | 9.3% | -90.3% |
| Net margin ⟶ | -1.6% | 3.0% | 1.4% | 4.8% | 4.7% | -10.0% | 0.2% | -20.2% | -18.5% | -9.1% | -118.9% |
| Revenue growth (1y) ⟶ | — | 36.0% | 13.3% | -0.1% | -0.4% | -13.4% | 22.4% | -4.5% | 8.7% | 3.2% | -2.0% |
| Revenue growth (5y CAGR) ⟶ | — | — | — | — | — | 5.8% | 3.6% | 0.1% | 1.8% | 2.6% | 4.4% |
| Net debt/EBITDA | 3.05x | 1.99x | 3.40x | 2.42x | 2.02x | 5.13x | 3.13x | 9.52x | 6.26x | 2.82x | — |
| Current ratio ⟶ | 1.15x | 1.22x | 1.11x | 1.04x | 1.03x | 1.19x | 0.83x | 0.71x | 0.71x | 1.04x | 0.28x |
The current year, quarter by quarter
As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.
| quarter | revenue | profit | net margin | P/E TTM | P/B | filed on |
|---|---|---|---|---|---|---|
| 2023T2! | 299.4 | -50.2 | -16.8% | -9.9 | 3.26 | 2023-08-10 |
| 2023T3! | 302.3 | -49.3 | -16.3% | -4.6 | 1.19 | 2023-11-07 |
| 2024T1! | 280.7 | -76.8 | -27.4% | -2.2 | 0.62 | 2025-04-15 |
| 2024T2! | 317.7 | 3.2 | 1.0% | -2.8 | 0.56 | 2025-04-15 |
| 2024T3! | 317.9 | 3.9 | 1.2% | -3.7 | 0.53 | 2025-04-15 |
| 2025T1! | 307.1 | -21.2 | -6.9% | -13.0 | 0.85 | 2025-05-15 |
| 2025T2! | 303.6 | -11.5 | -3.8% | -9.8 | 0.80 | 2025-08-14 |
| 2025T3! | 328.3 | 9.6 | 2.9% | -9.5 | 0.71 | 2025-11-14 |
Full series, every quarter: GET /empresas/AALR3/trimestres
Dividends per year
| year | per share | payments |
|---|---|---|
| 2020 | R$ 0.0873 | 1 |
| 2019 | R$ 0.0845 | 1 |
Piotroski F-Score 4/9 (2025) — what each criterion means.
Restated filings for this company
The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.
| fiscal year | account | first filing | restated |
|---|---|---|---|
| 2024 | DRE 3.01 | 1,217.0 | 1,177.5 |
| 2024 | DRE 3.02 | -861.3 | -833.5 |
| 2024 | DRE 3.03 | 355.7 | 344.1 |
| 2023 | DRE 3.08 | -19.1 | -12.7 |
| 2023 | DRE 3.09 | -218.6 | -212.1 |
| 2023 | DRE 3.11 | -218.6 | -212.1 |
| 2024 | DRE 3.11 | -111.2 | -117.2 |
| 2024 | DRE 3.08 | -15.8 | -21.3 |
This company appears in
Other companies in Healthcare
15 more with a page, same CVM sector — a classification of the regulator's, not ours.
Take this into your code
GET /empresas/AALR3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).Price coverage: 2,447 sessions, 2016-10-28 → 2026-09-04 · methodology · how we verify
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 12:12 UTC. If this does not match /saude, you are reading a cached copy.